A pharmaceutical company that sells a leading puberty blocker medication is a prominent corporate partner of a left-wing 501(c)3 promoting youth transgenderism.
AbbVie, Inc. is a Chicago-based pharmaceutical company that produces Lupron Depot, a drug that transitioning youth utilize to disrupt puberty while undergoing so-called “gender-affirming” healthcare.
Pediatric versions of Lupron are commonly used to stop early onset puberty and has become a popular medication for transgender youth in recent years, according to the Cleveland Clinic and RxRisk.Org. Versions of the drug designed for adults have been used to chemically castrate extreme sex offenders, according to clinical trial records from the National Center for Biotechnology Information.
The efficacy and risks of puberty blockers like Lupron have become flashpoint issues in the larger debate surrounding transgenderism and minors seeking to transition.
Texas Attorney General Ken Paxton launched an investigation into AbbVie in December 2021 for deceptively marketing Lupron, which Paxton called “reckless and dangerous” at the time. One month’s supply of Lupron at a 7.5 mg dosage can cost nearly $2,000, according to Drugs.com
AbbVie is also a corporate partner and supporter of the GenderCool Project, a 501(c)3 which aims to “replace misinformed opinions with positive experiences meeting transgender and non-binary youth who are thriving,” according to their website. The GenderCool Project actively promotes youth transgenderism in media, commercial entertainment and business. (RELATED: Amazon Sponsors ‘The GenderCool Project,’ An Org That Puts Gender Ideology Books In Kids’ Classrooms)
INSPIRE 💛💚〰️ “@AbbVie & Chief Equity Officer Rae Livingston thank you for inviting us to share our stories today & read from our new @AKidsBookAbout collection! This is how we change the world. Together.” –Champion Kai (he/him)🔍 https://t.co/ySfdfPLj2l #Pride2021 #GenderCool pic.twitter.com/oexZXeuvv2
— The GenderCool Project (@GenderCool) June 22, 2021
Activists from the GenderCool Project have appeared in media coverage from outlets including CNN, the New York Times, the Today Show, MSNBC, and USA Today. Some activists have even met with top White House officials like Secretary of Health and Human Services (HHS) Xavier Becerra, according to the organization’s website.
The GenderCool Project “is now a trusted source for top casting directors committed to evolving roles that reflect today’s youth,” its website states. The organization also writes and sells its own books for children about being transgender or non-binary. Oprah Winfrey promoted the books in 2020 as some of her “favorite things,” the group’s website states. (RELATED: ‘GenderCool Project’ Appears To Remove Nine Major Brands From Its Supporters Page)
Other corporate partners for the GenderCool Project include Nike, Intel, Dell and Allstate. The group also offers Diversity, Equity and Inclusion (DEI) consulting services and presentations, its website states.
Leadership for the GenderCool Project did not respond to requests an interview with the Daily Caller. The organization also did not respond to a request for written comment. Neither AbbVie, Inc. nor the AbbVie Foundation, the corporation’s philanthropy foundation, responded to the Daily Caller’s request for comment.